Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Masashi Funada"'
Autor:
Naoaki Ohkubo, Yusuke Miyazaki, Shingo Nakayamada, Shunsuke Fukuyo, Yoshino Inoue, Yurie Satoh-Kanda, Hiroaki Tanaka, Yasuyuki Todoroki, Hiroko Miyata, Atsushi Nagayasu, Masashi Funada, Hiroki Kobayashi, Hidenori Sakai, Shumpei Kosaka, Satsuki Matsunaga, Yukiko Tomoyose, Hirotsugu Nohara, Yoshiya Tanaka
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 5, Pp 1303-1319 (2024)
Abstract Introduction The study aimed to determine the efficacy and safety of biological disease-modifying antirheumatic drugs (bDMARDs) in the treatment of polymyalgia rheumatica (PMR) complicated by rheumatoid arthritis (RA). Methods Patients with
Externí odkaz:
https://doaj.org/article/4bf563ac6abb415f8bae6b44e3ae265f
Autor:
Hiroaki Tanaka, Satoshi Kubo, Shingo Nakayamada, Yusuke Miyazaki, Ippei Miyagawa, Koshiro Sonomoto, Masashi Funada
Publikováno v:
RMD Open, Vol 10, Iss 2 (2024)
Objective To investigate the early detection of pulmonary non-tuberculous mycobacterial (PNTM) disease by CT before the initiation of molecular-targeted therapeutic drugs in patients with rheumatoid arthritis (RA) and the efficacy and safety of combi
Externí odkaz:
https://doaj.org/article/9f24b13ac8bf4863b1a6b5a6a664896b
Autor:
Masao Nawata, Kazuki Someya, Masashi Funada, Yuya Fujita, Atsushi Nagayasu, Kazuyoshi Saito, Yoshiya Tanaka
Publikováno v:
BMC Rheumatology, Vol 5, Iss 1, Pp 1-8 (2021)
Abstract Background Improvements in the treatment of rheumatoid arthritis (RA) have made it possible to achieve treatment goals. It has been reported that both residual synovitis caused by RA and the patients’ subjective symptoms remain even after
Externí odkaz:
https://doaj.org/article/490f224f69ee46aba9dc3c8cabc66623
Autor:
Masao Nawata, Kazuki Someya, Takafumi Aritomi, Masashi Funada, Katsumi Nakamura, Kazuyoshi Saito, Yoshiya Tanaka
Publikováno v:
Rheumatology & Autoimmunity, Vol 1, Iss 1, Pp 9-17 (2021)
Abstract Background Subjective residual symptoms persist after clinical remission of rheumatoid arthritis (RA) in Japanese patients. Few studies have examined the relationship between these symptoms and subclinical inflammation using high‐sensitivi
Externí odkaz:
https://doaj.org/article/f5e05aaee5b344109c8147ca2bdd373f
Autor:
Masashi Funada, Yusuke Miyazaki, Shingo Nakayamada, Koshiro Sonomoto, Satoshi Kubo, Ippei Miyagawa, Hiroaki Tanaka, Yoshiya Tanaka
Publikováno v:
RMD Open; Apr2024, Vol. 10 Issue 2, p1-11, 11p
Autor:
Masao Nawata, Kazuki Someya, Shunpei Kosaka, Takafumi Aritomi, Masashi Funada, Yuya Fujita, Atsushi Nagayasu, Yoshihisa Fujino, Kazuyoshi Saito, Yoshiya Tanaka
Publikováno v:
Modern Rheumatology. 33:318-322
Objectives Differentiation between polymyalgia rheumatica (PMR) and elderly-onset rheumatoid arthritis (EORA), especially in elderly patients, is often difficult due to similarities in symptoms and serological kinetics. In this study, we aimed to ana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80a76d7511236a7843f2a2d7c000cdb7
https://doi.org/10.1093/mr/roac024
https://doi.org/10.1093/mr/roac024
Autor:
Takafumi Aritomi, Masashi Funada, Kazuki Someya, Yoshiya Tanaka, Kazuyoshi Saito, Katsumi Nakamura, Masao Nawata
Publikováno v:
Rheumatology & Autoimmunity. 1:9-17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98536ae8fbed20e033d6846a5666be5e
https://doi.org/10.1002/rai2.12006
https://doi.org/10.1002/rai2.12006
Autor:
Masao Nawata, Kazuki Someya, Shunpei Kosaka, Takafumi Aritomi, Masashi Funada, Yuya Fujita, Atsushi Nagayasu, Yoshihisa Fujino, Kazuyoshi Saito, Yoshiya Tanaka
Publikováno v:
Modern Rheumatology; Mar2023, Vol. 33 Issue 2, p318-322, 5p
Publikováno v:
Modern Rheumatology Case Reports. 5:11-15
Tumour necrosis factor (TNF) inhibitors are used against a variety of connective tissue diseases, including rheumatoid arthritis. Contrarily, although rare, TNF inhibitors are known to induce autoimmune diseases, such as systemic lupus erythematosus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88e3419d3bbcada5261d5b8435ab9698
https://doi.org/10.1080/24725625.2020.1798061
https://doi.org/10.1080/24725625.2020.1798061
Publikováno v:
Modern Rheumatology Case Reports. 4:229-232
Protein-losing enteropathy (PLE) is a rare organ disorder that can develop as a complication of systemic lupus erythematosus (SLE). Here, we report the case of a 59-year-old woman with SLE who experienced recurrent PLE resulting from different pathol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d13780752c3674811824c2f2f474a91
https://doi.org/10.1080/24725625.2020.1738988
https://doi.org/10.1080/24725625.2020.1738988